Cornerstone Capital Management Holdings’s Amicus Therapeutics FOLD Stock Holding History

Cornerstone Capital Management Holdings’s Portfolio FOLD Stock Details FOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	$992K	Buy	69,032 +500	+0.7%	+$6.87K	0.01%	901
2017 Q3	$1.03M	Sell	68,532 -10,100	-13%	-$134K	0.01%	921
2017 Q2	$791K	Sell	78,632 -7,415	-9%	-$59.7K	0.01%	959
2017 Q1	$612K	Buy	+86,047	New	+$544K	﹤0.01%	1020
2016 Q4	–	Sell	-1,800	Closed	-$13K	–	1358
2016 Q3	$13K	Buy	+1,800	New	+$12.2K	﹤0.01%	1332
2016 Q1	–	Sell	-4,100	Closed	-$40K	–	1513
2015 Q4	$40K	Sell	4,100 -5,900	-59%	-$53.2K	﹤0.01%	1383
2015 Q3	$140K	Buy	+10,000	New	+$157K	﹤0.01%	1280

Other funds holding FOLD

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Cornerstone Capital Management Holdings's FOLD Position: Q4 2017 in Review

Cornerstone Capital Management Holdings increased its Amicus Therapeutics (FOLD) stake by 0.73% in Q4 2017, buying an estimated $6.87K and bringing the position to 69,032 shares worth $992K. The position accounts for 0.01% of the portfolio, ranked #901.

Cornerstone Capital Management Holdings first reported a position in FOLD in Q3 2015 and has held it in 7 quarters since. The position peaked at $1.03M in Q3 2017. 185 funds tracked by Wall St. Rank hold FOLD as of Q4 2017.

Cornerstone Capital Management Holdings held 69,032 shares of Amicus Therapeutics worth $992K as of Q4 2017.
Cornerstone Capital Management Holdings bought 500 Amicus Therapeutics shares in Q4 2017, an estimated $6.87K.
Amicus Therapeutics made up 0.01% of Cornerstone Capital Management Holdings's portfolio in Q4 2017, its #901 holding.
Cornerstone Capital Management Holdings first reported a position in Amicus Therapeutics in Q3 2015 and has held it in 7 quarters since.
Cornerstone Capital Management Holdings's Amicus Therapeutics position peaked at $1.03M in Q3 2017.
185 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q4 2017.

Based on Cornerstone Capital Management Holdings's 13F filing for Q4 2017, filed 14 Feb 2018.